Diabetes Initiative

Diabetes is a chronic metabolic disorder that affects how the body processes blood sugar (glucose). It occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone responsible for regulating blood sugar levels, ensuring cells receive the energy they need.

There are three main types of diabetes: Type 1, Type 2, and Gestational Diabetes. Type 1 diabetes is an autoimmune condition where the body’s immune system attacks insulin-producing cells. It typically develops in childhood or adolescence and requires lifelong insulin therapy. Type 2 diabetes is the most common form and is largely influenced by lifestyle factors such as poor diet, lack of exercise, and obesity. It can often be managed through diet, exercise, and medication. Gestational diabetes occurs during pregnancy and increases the risk of developing Type 2 diabetes later in life.

Common symptoms include frequent urination, excessive thirst, unexplained weight loss, fatigue, and slow wound healing. If left untreated, diabetes can lead to severe complications such as heart disease, kidney failure, nerve damage, and vision loss.

Managing diabetes involves a balanced diet, regular exercise, medication or insulin therapy, and routine blood sugar monitoring. Herbal and nutraceutical solutions are also gaining attention for their potential in blood sugar regulation. Early diagnosis and proper management can help individuals lead a healthy life despite having diabetes.

Research Progress

.

The Open Science Institute’s Diabetes Initiative has now progressed to the First phase — Systems Architecture.

We need your support to move forward. Our goal is to raise $2.5 Million to research and reveal to the scientific community, highlighting the powerful potential of stem cells in regenerative health. Please support this initiative.

Systems Architecture

The Systems Architecture of Diabetes is published as a Web-based tool open to public. Click below to interact with the systems architecture

Publication

A peer-reviewed publication from the Diabetes Initiative will be released soon to benefit the public by revealing powerful insights into the use of stem cells for treating diseased conditions—support this initiative to advance scientific discovery and deliver real solutions through regenerative medicine.

In silico Modeling

In this phase, the Diabetes Initiative will conduct in silico modeling to identify and test the efficacy of mesenchymal stem cells on tissue regeneration, immune modulation and anti-fibrosis activity. This phase is yet to begin.

Combination Screening

Patents

The Open Science Institute® through its diabetes initiative is moving towards getting patents for a revolutionary mesenchymal stem cells that affects tissue regeneration, immune modulation and anti-fibrosis activity.

Licensing and Manufacturing

The Diabetes Initiative plans to discover, develop, license and manufacture a MSC product which supports treatment of many diseases. Support our mission to bring this innovation to those who need it most. Please support this Phase by donating to the Diabetes Initiative